간세포암종의 안와 전이 1예
A Case of Metastatic Hepatocellular Carcinoma of the Orbit
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Orbital metastasis from hepatocellular carcinoma is very rare, with only 14 biopsy-proven cases from hepa tocellular carcinoma cases reported in English literature and three cases reported in Korea. Common symptoms of orbital metastasis are proptosis, visual loss, ocular pain and oculomotor dysfunction. For its precise diagnosis, we can perform fine needle aspiration biopsy, orbit CT or MRI, and ultrasonography. Radiotherapy is the mainstay in the treatment of orbital metastasis. In addition, chemotherapy, hormonal therapy and surgical intervention can play a role in the treatment of orbital metastasis according to the primary cancer and symptoms. However, the prognosis of orbital metastasis is poor. We report herein a rare case of a patient with orbital metastasis from hepatocellular carcinoma, which was treated with various modalities that included resection, and who had good clinical and radiological responses to radiation therapy and sorafenib (Nexavar, Bayer HealthCare).
Abstract
Orbital metastasis from hepatocellular carcinoma is very rare, with only 14 biopsy-proven cases from hepa tocellular carcinoma cases reported in English literature and three cases reported in Korea. Common symptoms of orbital metastasis are proptosis, visual loss, ocular pain and oculomotor dysfunction. For its precise diagnosis, we can perform fine needle aspiration biopsy, orbit CT or MRI, and ultrasonography. Radiotherapy is the mainstay in the treatment of orbital metastasis. In addition, chemotherapy, hormonal therapy and surgical intervention can play a role in the treatment of orbital metastasis according to the primary cancer and symptoms. However, the prognosis of orbital metastasis is poor. We report herein a rare case of a patient with orbital metastasis from hepatocellular carcinoma, which was treated with various modalities that included resection, and who had good clinical and radiological responses to radiation therapy and sorafenib (Nexavar, Bayer HealthCare).
참고문헌 (10)
- Park JW, "Hepatocellular carcinoma in Korea: introduction and overview", Korean J Gastroenterol, 45, pp.217~226 (2005)
- Hirunwiwatkul P, "Orbital metastasis of hepatocellular carcinoma", J Neuroophthalmol, 28, pp.47~50 (2008)
- Park JY, "A case of metastatic hepatocellular carcinoma to orbit with superior orbital fissure syndrome", Korean J Med, 60, pp.179~182 (2001)
- Kim IT, "Hepatocellular carcinoma metastatic to the orbit", Korean J Ophthalmol, 14, pp.97~102 (2000)
- Byon D, "Orbital metastasis of hepatocellular carcinoma", J Korean Ophthalmol Soc, 39, pp.1594~1597 (1998)
- Ahmad SM, "Metastatic tumors of the orbit and ocular adnexa", Curr Opin Ophthalmol, 18, pp.405~413 (2007)
- Char DH, "Orbital metastases: diagnosis and course", Br J Ophthalmol, 81, pp.386~390 (1997)
- Amemiya T, "Metastatic orbital tumors in Japan: a review of the literature", Ophthalmic Epidemiol, 9, pp.35~47 (2002)
- Uchino K, "Hepatocellular carcinoma with extrahepatic metastasis:clinical features and prognostic factors", Cancer, 117, pp.4475~4483 (2011)
- Oida Y, "Hepatocellular carcinoma metastatic to the orbit: a case report", Tokai J Exp Clin Med, 31, pp.7~10 (2006)